NDC 0407-0734 - HYPAQUE - CYSTO
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0407-0734
- Package NDCs from labels
- 0407-0734-10
- Manufacturer
- Amersham Health Inc.
- Effective date
- 2007-08-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYPAQUE-CYSTO™ (Diatrizoate Meglumine Injection, USP) 30% | Amersham Health Inc. | 2007-08-03 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0407-0734-10 | HYPAQUE - CYSTO | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 1 | |
| 0407-0734-10 | HYPAQUE - CYSTO | 500 mL in 1 BOTTLE | INJECTION, SOLUTION | 500 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| diatrizoate meglumine | ACTIVE INGREDIENT | 3X9MR4N98U | HYPAQUE - CYSTO (DIATRIZOATE MEGLUMINE) INJECTION, SOLUTION [AMERSHAM HEALTH INC.] | 1 | |
| diatrizoic acid | ACTIVE MOIETY | 5UVC90J1LK | HYPAQUE - CYSTO (DIATRIZOATE MEGLUMINE) INJECTION, SOLUTION [AMERSHAM HEALTH INC.] | 1 | |
| Iodine | INACTIVE INGREDIENT | 9679TC07X4 | HYPAQUE - CYSTO (DIATRIZOATE MEGLUMINE) INJECTION, SOLUTION [AMERSHAM HEALTH INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7AACCC2D-AC14-8C7C-940A-BA4A8BF5AB3C | 7E20C7B5-8A7D-4AE6-BA73-0E6EEEB2016E | 2007-08-03 | Warnings, Adverse reactions | 7AACCC2D-AC14-8C7C-940A-BA4A8BF5AB3C 7E20C7B5-8A7D-4AE6-BA73-0E6EEEB2016E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.